Trial Profile
Dual regimen of lamivudine and ritonavir-boosted darunavir in patients with HIV infections
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2015
Price :
$35
*
At a glance
- Drugs Darunavir/ritonavir (Primary) ; Lamivudine (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 09 Nov 2015 New trial record